NCT06721143
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy with AION-301 Administered by Intravenous Infusion Compared with Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age with Chronic Kidney Disease (CKD)
Phase: Phase 1/2
Role: Collaborator
Start: Jan 23, 2025
Completion: Dec 31, 2027